Literature DB >> 20093337

Effect of intra-aortic balloon pump support on microcirculation during high-risk percutaneous intervention.

Christian Jung1, Alexander Lauten, Christoph Rödiger, Florian Krizanic, Hans R Figulla, Markus Ferrari.   

Abstract

BACKGROUND: Intra-aortic balloon counter-pulsation (IABP) is recommended for hemodynamic support in cardiogenic shock. In addition, it can be applied during high-risk percutaneous interventions (PCI). While IABP support improves microflow in cardiogenic shock, its effect in hemodynamically stable patients is still unclear. We, therefore, sought to evaluate the effect of IABP treatment on microflow in hemodynamically stable patients undergoing elective high-risk PCI.
METHODS: In six patients with >50% left main stenosis, microflow was evaluated according to current guidelines, using side-stream dark-field microscopy, visualizing microcirculatory vessels without using fluorescent dyes. Microflow was analyzed separately for each vessel category (diameter: 10-25microm and 26-50microm), using a semiquantitative system (0= no flow; 1= intermittent flow; 2= sluggish flow; 3= continuous flow) by a trained investigator. Steady state recordings and additional recordings twenty seconds after discontinuation of the electively implanted IABP were acquired.
RESULTS: Microflow in vessel categories 10-25microm and 26-50microm increased in this group of hemodynamically stable patients on use of IABP. Microflow decreased from 2.73 + or - 0.39 (p=0.052; 26-50microm: 2.88 + or - 0.20, p=0.008) to 2.22 + or - 0.23 (2.18 + or - 0.45) after stopping the IABP and increased to 2.90 + or - 0.14 (p=0.009; 2.85 + or - 0.28, p=0.009) after restart of the IABP.
CONCLUSIONS: Circulatory support with IABP increases microcirculatory flow in the smallest vessels of the sublingual mucosa. Our data support the hypothesis that intra-aortic balloon counter-pulsation increases coronary and microvascular perfusion, thus, improving microcirculation even in hemodynamically stable patients. The use of IABP may increase safety of complex PCI and decrease the risk of deleterious complications.

Entities:  

Mesh:

Year:  2009        PMID: 20093337     DOI: 10.1177/0267659109358208

Source DB:  PubMed          Journal:  Perfusion        ISSN: 0267-6591            Impact factor:   1.972


  6 in total

1.  Intraaortic balloon counterpulsation and microcirculation in cardiogenic shock complicating myocardial infarction: an IABP-SHOCK II substudy.

Authors:  Christian Jung; Georg Fuernau; Suzanne de Waha; Ingo Eitel; Steffen Desch; Gerhard Schuler; Hans R Figulla; Holger Thiele
Journal:  Clin Res Cardiol       Date:  2015-02-27       Impact factor: 5.460

2.  Acute myocardial infarction and cardiogenic shock: prognostic impact of cytokines: INF-γ, TNF-α, MIP-1β, G-CSF, and MCP-1β.

Authors:  R Prondzinsky; S Unverzagt; H Lemm; N Wegener; K Heinroth; U Buerke; M Fiedler; J Thiery; J Haerting; K Werdan; M Buerke
Journal:  Med Klin Intensivmed Notfmed       Date:  2012-07-20       Impact factor: 0.840

3.  Impact of rapid ventricular pacing during TAVI on microvascular tissue perfusion.

Authors:  Anna Selle; Hans R Figulla; Markus Ferrari; Wilma Rademacher; Bjoern Goebel; Ali Hamadanchi; Marcus Franz; Andrea Schlueter; Thomas Lehmann; Alexander Lauten
Journal:  Clin Res Cardiol       Date:  2014-06-05       Impact factor: 5.460

4.  [Assessment of microcirculation in critically ill patients].

Authors:  C Jung; M Kelm; M Ferrari
Journal:  Med Klin Intensivmed Notfmed       Date:  2016-06-09       Impact factor: 0.840

5.  A longer total duration of rapid ventricular pacing does not increase the risk of postprocedural myocardial injury in patients who undergo transcatheter aortic valve implantation.

Authors:  Kenta Okitsu; Takeshi Iritakenishi; Tatsuyuki Imada; Mitsuo Iwasaki; Sho Carl Shibata; Yuji Fujino
Journal:  Heart Vessels       Date:  2017-03-20       Impact factor: 2.037

6.  Withdrawing intra-aortic balloon pump support paradoxically improves microvascular flow.

Authors:  Luuk D H Munsterman; Paul W G Elbers; Alaattin Ozdemir; Eric P A van Dongen; Mat van Iterson; Can Ince
Journal:  Crit Care       Date:  2010-08-25       Impact factor: 9.097

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.